Hyperinsulinemia: effect on cardiac mass/function, angiotensin II receptor expression, and insulin signaling pathways - Wikidata - wikimedia - TriplyDB

Hyperinsulinemia: effect on cardiac mass/function, angiotensin II receptor expression, and insulin signaling pathways

Hyperinsulinemia: effect on cardiac mass/function, angiotensin II receptor expression, and insulin signaling pathways

http://www.wikidata.org/entity/Q28565051

about

Over-expression of NYGGF4 inhibits glucose transport in 3T3-L1 adipocytes via attenuated phosphorylation of IRS-1 and Akt Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2 Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase Insulin Signaling and Heart Failure.Co-activation of nuclear factor-κB and myocardin/serum response factor conveys the hypertrophy signal of high insulin levels in cardiac myoblasts.Cardiovascular impact of drugs used in the treatment of diabetes Myocardial insulin resistance induced by high fat feeding in heart failure is associated with preserved contractile function.Effects of insulin therapy on myocardial lipid content and cardiac geometry in patients with type-2 diabetes mellitus.Nexilin, a cardiomyopathy-associated F-actin binding protein, binds and regulates IRS1 signaling in skeletal muscle cells.Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study.An early response transcription factor, Egr-1, enhances insulin resistance in type 2 diabetes with chronic hyperinsulinism The Impact of Overnutrition on Insulin Metabolic Signaling in the Heart and the Kidney Egr-1 decreases adipocyte insulin sensitivity by tilting PI3K/Akt and MAPK signal balance in mice Cardiac insulin resistance and microRNA modulators.Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities.Reactive Oxygen Species and Nuclear Factor Erythroid 2-Related Factor 2 Activation in Diabetic Nephropathy: A Hidden Target Insulin signaling pathways and cardiac growth.Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats Insulin signalling in the heart.Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets.Increased cord blood angiotensin II concentration is associated with decreased insulin sensitivity in the offspring of mothers with gestational diabetes mellitus.Non-canonical signalling and roles of the vasoactive peptides angiotensins and kinins.Apelin-13 promotes cardiomyocyte hypertrophy via PI3K-Akt-ERK1/2-p70S6K and PI3K-induced autophagy.How cardiomyocytes sense pathophysiological stresses for cardiac remodeling.A static pressure sensitive receptor APJ promote H9c2 cardiomyocyte hypertrophy via PI3K-autophagy pathway.Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents.Coconut Oil Aggravates Pressure Overload-Induced Cardiomyopathy without Inducing Obesity, Systemic Insulin Resistance, or Cardiac Steatosis Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats.Insulin resistance and left ventricular hypertrophy in end-stage renal disease: association between the ENPP1 gene and left ventricular concentric remodelling.Downregulation of the ACE2/Ang-(1-7)/Mas axis in transgenic mice overexpressing GH.Hyperinsulinemic rats are normotensive but sensitized to angiotensin II.Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse.Restraint stress exacerbates cardiac and adipose tissue pathology via β-adrenergic signaling in rats with metabolic syndrome.ACE-inhibition induces a cardioprotective transcriptional response in the metabolic syndrome heart Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure

P2860

Q24329181-F2BF173F-BC31-4358-963D-B53708C6F8EA Q28272571-E380F727-986E-4DD1-A5BB-277D90B3E253 Q28575707-23BE0B41-E9CF-4152-8644-52D5E91CA834 Q30377910-A5EABDB9-6058-4E5A-8DBC-017DF01A8B2F Q33888579-6205B250-77D4-4116-932D-13DFBCF875E2 Q34383575-DF30115C-D00F-4DB6-BDF2-37C64253D846 Q34426167-B73AFCF1-3D60-4DA4-A24F-653CC0994CF4 Q34506453-39D0DEB3-0840-4890-9777-76022E30A591 Q34576839-B50CE02F-3B9F-4CDD-9E35-7B9F98377FD8 Q34670148-8C4D3E54-530E-4BAA-B8BC-F0447B70A2B0 Q34800387-DA11A258-64EA-45CC-93B5-35EF042F1C52 Q35005356-39B34DE8-A737-4FEB-900A-8231531626E3 Q35214910-003AB7AB-6DB0-4481-AEC1-AF9033D7DD88 Q35251097-18D83201-2712-47E6-82F7-EE3CCB3B1942 Q35789287-2933B472-B568-45FF-837B-A815292B0D1E Q35880186-0360DCC1-1618-465E-9A8D-DA483BA46C17 Q36742620-2977BCD0-A034-4833-B1A8-C79095455960 Q36946065-8F579D7C-22EF-4444-8B09-9007B4553DA9 Q37129268-5E4AC316-ED3F-4D78-AB71-A101F9817FF2 Q37832957-4FE690D6-D765-438C-9C92-440455D63F7E Q38002327-5BB354A4-D118-43A1-886B-1AB603BB7831 Q38190099-D0C5FB42-6322-4F12-A53C-79ED8E4C9D42 Q38816685-6AE50FF4-2E25-4E2A-ACED-08DCA6C0265E Q38974621-22ED1B6C-734D-4D95-97A5-B7A9EA5CB728 Q38981187-67DF2953-7F65-4C16-A0A6-5FD14356D5FE Q40238333-7DC9F148-169A-46C4-B61E-E5B5521B44F5 Q41183300-9936E19E-4B34-466A-9202-1710A99CF33E Q43121287-148BC952-BAC8-416C-8D84-834B5D981E50 Q45891859-667E4968-816E-488F-98AF-1B339DC6F439 Q46230592-967A5FB9-C04B-435E-9D00-27697DB7F582 Q46794027-6D3F051F-C287-4F48-AFB2-29F074A9619F Q51775769-74124861-F4F9-46BA-AE81-EB20DE6882F7 Q53584189-396D256E-F43B-47A9-B28D-7CE1F7E70797 Q58577455-31690F34-41F1-4BEE-B784-F13E7395C4A6 Q58946977-F50243EC-61AE-4D25-B3B1-CE01DE4F98FF

P2860

Hyperinsulinemia: effect on cardiac mass/function, angiotensin II receptor expression, and insulin signaling pathways

http://www.wikidata.org/entity/Q28565051

description

2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2006

@ast

im August 2006 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2006/08/01)

@sk

vědecký článek publikovaný v roce 2006

@cs

wetenschappelijk artikel (gepubliceerd op 2006/08/01)

@nl

наукова стаття, опублікована в серпні 2006

@uk

مقالة علمية (نشرت في أغسطس 2006)

@ar

name

Hyperinsulinemia: effect on ca ...... and insulin signaling pathways

@ast

Hyperinsulinemia: effect on ca ...... and insulin signaling pathways

@en

Hyperinsulinemia: effect on ca ...... and insulin signaling pathways

@nl

type

label

Hyperinsulinemia: effect on ca ...... and insulin signaling pathways

@ast

Hyperinsulinemia: effect on ca ...... and insulin signaling pathways

@en

Hyperinsulinemia: effect on ca ...... and insulin signaling pathways

@nl

prefLabel

Hyperinsulinemia: effect on ca ...... and insulin signaling pathways

@ast

Hyperinsulinemia: effect on ca ...... and insulin signaling pathways

@en

Hyperinsulinemia: effect on ca ...... and insulin signaling pathways

@nl

P1433

Q28565051-E981385E-08B8-4280-A733-E9815E9C0660

P1476

Q28565051-B3451C51-65F1-4E8C-A50A-64F915C24393

P2093

Q28565051-06725570-04EC-474E-A7C9-C85439B28F8B

Q28565051-1FBCCAE4-0511-4A7C-860C-D426EB197291

Q28565051-33CF9077-2C65-4B76-88CB-B6F74C6C0F79

Q28565051-701B98D1-975D-43C8-8059-38F46F83F114

Q28565051-9A856080-3D80-4022-AA68-F60C5B52C329

Q28565051-D46A2F39-8366-4F5B-97D6-AEA10A1026A7

Q28565051-DBF788B5-4E54-41DF-9A2C-070342044582

P2860

Q28565051-04CB9B66-D003-408F-B810-387DFE477D4D

Q28565051-0C525C30-844D-469A-A5C4-503CCC38578F

Q28565051-13BB3ED2-E911-42B5-B747-8DA311EDBF08

Q28565051-1472EE4C-57A7-47BA-8AF8-20D21E33CE81

Q28565051-197D42C4-4B18-48E6-9166-A21FE9A60A56

Q28565051-1AEE486E-AEF9-4A3E-8245-88ADECBCF246

Q28565051-1C472DBC-716D-4482-A694-1E0028DAC80B

Q28565051-25C9D076-5E99-421C-98A9-2BE792854369

Q28565051-2AB8B61B-976C-42BD-B9C8-A3E1C9A0B2E2

Q28565051-2B19495F-7B92-4537-8EB3-E68EFD67D1CA

P304

Q28565051-9A3BDD47-B893-402B-BD53-7CC0631ACADD

P31

Q28565051-03B87F3E-4419-4BC6-BC62-ADF8E3061269

P356

Q28565051-D15802D2-7411-40A6-9138-67C172823BA7

P433

Q28565051-79B07E6F-40AE-4CDB-8323-396EBEF092DB

P478

Q28565051-BFFD45F5-99F4-449E-B4FB-BA6A87E4DA8C

P50

Q28565051-72C6E048-7101-4864-B959-08B7377D1321

P577

Q28565051-C9F07CED-D5C2-4910-ABF8-18D11568E380

P5875

Q28565051-BEB400B8-1172-42E7-8DF6-24A49D6F684E

P698

Q28565051-0EDF1C71-5486-4B76-AD6B-0CDF44A449A1

P921

Q28565051-D30DE8B4-9F41-4954-9B43-EABC73BC1615

P356

AJPHEART.00974.2005

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Hyperinsulinemia: effect on ca ...... and insulin signaling pathways

@en

P2093

Anne-Maj Samuelsson

http://www.w3.org/2001/XMLSchema#string

Britt-Mari Larsson

http://www.w3.org/2001/XMLSchema#string

Elmir Omerovic

http://www.w3.org/2001/XMLSchema#string

Entela Bollano

http://www.w3.org/2001/XMLSchema#string

Finn Waagstein

http://www.w3.org/2001/XMLSchema#string

Michael Fu

http://www.w3.org/2001/XMLSchema#string

Reza Mobini

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation

Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

Alternative splicing: a novel mechanism to fine-tune the expression and function of the human AT1 receptor

Positive and negative regulation of insulin signaling through IRS-1 phosphorylation

Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling

G-protein and tyrosine kinase receptor cross-talk in rat aortic smooth muscle cells: thrombin- and angiotensin II-induced tyrosine phosphorylation of insulin receptor substrate-1 and insulin-like growth factor 1 receptor

Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase

P304

H787–796

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.00974.2005

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

291

http://www.w3.org/2001/XMLSchema#string

P50

Agneta Holmäng

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7214574

http://www.w3.org/2001/XMLSchema#string

P698

16565309

http://www.w3.org/2001/XMLSchema#string

P921